In addition to statins, ACE inhibitors, and aspirin to reduce the risk of CVD (see Treatment of Atherosclerosis), a recent randomized, placebo-controlled trial showed that low-dose rivaroxaban when added to aspirin alone reduced CVD events and major adverse limb events, including amputation (1).